{"i":{"6":{"name":"1 moxonidine","spans":[{"i":"3417","f":"3427","txt":"moxonidine"},{"i":"3636","f":"3646","txt":"moxonidine"},{"i":"4574","f":"4584","txt":"moxonidine"},{"i":"4650","f":"4660","txt":"moxonidine"},{"i":"4842","f":"4852","txt":"moxonidine"},{"i":"4974","f":"4984","txt":"moxonidine"},{"i":"-1","f":"-1","txt":"Moxonidine"}]},"13":{"name":"2 nitrendipine","spans":[{"i":"3472","f":"3484","txt":"nitrendipine"},{"i":"4483","f":"4495","txt":"nitrendipine"},{"i":"4757","f":"4769","txt":"nitrendipine"},{"i":"4900","f":"4912","txt":"nitrendipine"},{"i":"5012","f":"5024","txt":"nitrendipine"},{"i":"-1","f":"-1","txt":"Nitrendipine"}]}},"o":{"19":{"name":"1 cost per life-year gained","spans":[{"i":"4149","f":"4174","txt":"cost per life-year gained"}]},"21":{"name":"2 percentage of patients progressing to ESRD","spans":[{"i":"4180","f":"4222","txt":"percentage of patients progressing to ESRD"},{"i":"4496","f":"4514","txt":"progressed to ESRD"}]},"23":{"name":"3 cumulative costs","spans":[{"i":"4227","f":"4243","txt":"cumulative costs"},{"i":"4781","f":"4797","txt":"cumulative costs"}]},"27":{"name":"4 number of ESRD cases","spans":[{"i":"4689","f":"4709","txt":"number of ESRD cases"},{"i":"-1","f":"-1","txt":"ESRD cases"}]},"29":{"name":"5 life-years lived","spans":[{"i":"5037","f":"5053","txt":"life-years lived"},{"i":"5734","f":"5750","txt":"life-years lived"},{"i":"-1","f":"-1","txt":"Life-years lived"}]},"32":{"name":"6 cost-saving","spans":[{"i":"5098","f":"5109","txt":"cost-saving"}]},"34":{"name":"7 Costs per patient","spans":[{"i":"-1","f":"16","txt":"Costs per patient"}]}}}